-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Author: Probiotics
Recently, Hengrui Medicine held an extraordinary general meeting of shareholders.
In fact, not only Hengrui, but in the context of deepening pharmaceutical reforms, it is nothing new for domestic and foreign pharmaceutical companies to abolish their sales teams in large numbers
The author believes that there are two reasons for the adjustment of the pharmaceutical representative industry: one is that the sales team expanded too fast in the past, and there was redundancy in itself, which caused the situation of "more wolves and less meat", and in some places the hierarchy was complicated, and some places were inefficient; Most generic drugs are included in centralized procurement, there is no market vacancy, and corporate sales staff do not need so many
So how should companies adjust? Take Hengrui Medicine as an example.
1.
1.
2.
2.
Due to the policy nature of the pharmaceutical industry, the market price and sales volume of products are greatly affected by the policy
Since the national organization of the "4+7" drug pilot project in 2018, whether it is viewed vertically or horizontally, the centralized drug procurement has made breakthrough developments in the process of groping forward
3.
3.
However, non-compliant sales have also brought a great negative impact on the industry.
In recent years, the state has gradually increased the regulations and restrictions on medical representatives.
Opportunities and challenges coexist.
Will the "medical representatives" be adjusted in the future? The author believes that it will certainly be, but representatives who can comprehensively consider the internal and external development of the industry and provide professional product knowledge will stand firm and help China's medical academic promotion cause another success
Short-term "variables" have caused a "quantitative change" in the medical representative group, but in the long run, we will see a "qualitative change" in this group
.
